McKesson (MCK) Stock Price, Quote, News & History | Benzinga

McKesson Corp (MCK) Stock Price, Quote, News & History

MCKNYSE

Trade with Public

Trade with Public

$905.09

31.303.58%

At close: Aug 25, 5:00 PM EST

$905.09

N/A

After Hours: 4:19 PM EST

Dividend: The dividend Ex-Date is in 7 days

M&A: Precision Medicine Group, LLC announced today it will be acquired by McKesson (MCK) for $2.3B

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Dividends Compare Options Stock Report

Key Statistics

Open

$871.40

Close

$905.09

Volume / Avg.

882.55K / 1.09M

Day Range

$869.37 - $905.66

52 Wk Range

673.38 - 999.00

Market Cap

$105.52B

P/E Ratio

23.44

Dividend Yield

0.43%

Exchange

NYSE

RSI

62

Short Interest

3.1%

Days to Cover

3.84

Recent McKesson Corp News

McKesson Buys Precision Medicine to Expand Clinical Research and Commercialization

McKesson will acquire Precision Medicine Group for $2.25 billion, expanding its clinical research and drug commercialization services.

Vandana Singh

Amazon Ends Walmart's 13‑Year Hold On The S&P 500 Revenue Crown — But There's A Catch

The battle between Amazon.com and Walmart has produced a new leader for the Fortune 500 list for 2025 revenue.

Chris Katje

Nasdaq Tops 29,000 Records, Micron Soars 13%: Stock Market Today

Nasdaq jumps 1.6% to record highs Friday as semiconductor rally and stronger-than-expected April payrolls overshadow ongoing Strait of Hormuz tensions.

Piero Cingari

Gavin Newsom Hails Apple's '50 Years Of Innovation' As Tesla, Chevron, McKesson Leave California

Gavin Newsom praised Apple's 50 years of innovation as numerous major corporations and tech billionaires relocate from California.

Ananya Gairola

Trump Ally Mullin Goes Stock Shopping Again: Here's His Latest Buys, Including Potential Conflict Of Interest

Sen. Markwayne Mullin has been buying shares of smaller companies in recent months. Here are his latest transactions and why one stock is catching attention.

Chris Katje

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

6.85B

Investing Cash Flow (TTM)

-82.00M

Financing Cash Flow (TTM)

-4.18B

Free Cash Flow (TTM)

6.15B

Capital Expenditure (TTM)

-708.00M

Net Change in Cash (TTM)

2.60B

Analyst Trends and Forecast

4

Apr

4

1

May

1

Jun

2

Jul

4

1

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$108.41B

PE Ratio (TTM)

23.44

PE Ratio (FWD)

19.65

PEG Ratio (TTM)

1.66

PS Ratio (TTM)

0.26

PB Ratio (TTM)

-

Earnings Yield % (TTM)

4.27%

Earnings Yield % (FWD)

5.09%

EV / EBITDA (TTM)

14.46

Price / EBITDA (TTM)

14.27

Price / Free Cash Flow (TTM)

17.42

Book Value / Share

-$36.37

Company Debt

Total Debt

$9.73B

LT Debt

$8.43B

LT Debt Issuance (TTM)

$3.22B

LT Debt Repayment (TTM)

-$1.21B

Total Cash

$5.16B

Debt to Equity

-

Issuance of Debt (TTM)

$2.01B

Repayment of Debt (TTM)

-$10.46B

Key Statistics

Open

$871.40

Close

$905.09

Volume / Avg.

882.55K / 1.09M

Day Range

$869.37 - $905.66

52 Wk Range

673.38 - 999.00

Market Cap

$105.52B

P/E Ratio

23.44

Dividend Yield

0.43%

Exchange

NYSE

RSI

62

Short Interest

3.1%

Days to Cover

3.84

About

Sector

Health Care

Industry

Health Care Providers & Services

McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and hea...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

Q

How do I buy McKesson (MCK) stock?

A

You can purchase shares of McKesson (NYSE:MCK) through any online brokerage.

View our list of the best stock brokerages

Q

Who are McKesson (MCK) competitors?

A

Other companies in McKesson’s space includes: Cencora Inc (NYSE:COR), Cardinal Health Inc (NYSE:CAH), Henry Schein Inc (NASDAQ:HSIC), AdaptHealth Corp (NASDAQ:AHCO) and Akso Health Group (NASDAQ:AHG).

Q

What is the forecast, or price target, for McKesson (MCK) stock?

A

McKesson has a consensus price target of $876.63.

Q

What is the current price for McKesson (MCK)?

A

The stock price for McKesson (NYSE: MCK) is $905.09 last updated August 25, 2026 at 4:19 PM EDT.

Q

Does McKesson (MCK) pay a dividend?

A

There are no upcoming dividends for McKesson.

Q

When is McKesson (NYSE:MCK) reporting earnings?

A

McKesson does not have any upcoming earnings scheduled.

Q

Is McKesson (MCK) going to split?

A

There is no upcoming split for McKesson.

Q

What sector and industry does McKesson (MCK) operate in?

A

McKesson is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NYSE.